» Articles » PMID: 39690206

A Consensus Platform for Antibody Characterization

Abstract

Antibody-based research applications are critical for biological discovery. Yet there are no industry standards for comparing the performance of antibodies in various applications. We describe a knockout cell line-based antibody characterization platform, developed and approved jointly by industry and academic researchers, that enables the systematic comparison of antibody performance in western blot, immunoprecipitation and immunofluorescence. The scalable protocols, which require minimal technological resources, consist of (1) the identification of appropriate cell lines for antibody characterization studies, (2) development/contribution of isogenic knockout controls, and (3) a series of antibody characterization procedures focused on the most common applications of antibodies in research. We provide examples of expected outcomes to guide antibody users in evaluating antibody performance. Central to our approach is advocating for transparent and open data sharing, enabling a community effort to identify specific antibodies for all human proteins. Mid-level graduate students with training in biochemistry and prior experience in cell culture and microscopy can complete the protocols for a specific protein within 1 month while working part-time on this effort. Antibody characterization is needed to meet standards for resource validation and data reproducibility, which are increasingly required by journals and funding agencies.

Citing Articles

A guide to selecting high-performing antibodies for CSNK1A1 (UniProt ID: P48729) for use in western blot, immunoprecipitation, and immunofluorescence.

Ayoubi R, Alende C, Fotouhi M, Ruiz Moleon V, Gonzalez Bolivar S, Southern K F1000Res. 2025; 13:1055.

PMID: 40028451 PMC: 11868743. DOI: 10.12688/f1000research.155928.1.


A guide to selecting high-performing antibodies for ADNP (UniProt ID: Q9H2P0) for use in western blot, immunoprecipitation, and immunofluorescence.

Ruiz Moleon V, Alende C, Fotouhi M, Ayoubi R, Gonzalez Bolivar S, Laflamme C F1000Res. 2025; 13:1545.

PMID: 39949964 PMC: 11822250. DOI: 10.12688/f1000research.160121.1.


A guide to selecting high-performing antibodies for VAPB (UniProt ID: O95292) for use in western blot, immunoprecipitation, and immunofluorescence.

Gonzalez Bolivar S, Ayoubi R, Alende C, Fothouhi M, Shlaifer I, McPherson P F1000Res. 2025; 13:1559.

PMID: 39916983 PMC: 11799760. DOI: 10.12688/f1000research.160226.1.


A guide to selecting high-performing antibodies for Huntingtin (UniProt ID: P42858) for use in western blot, immunoprecipitation, and immunofluorescence.

Fanti R, Ayoubi R, Alende C, Fotouhi M, Gonzalez Bolivar S, Chandrasekaran R F1000Res. 2024; 13:922.

PMID: 39257448 PMC: 11384196. DOI: 10.12688/f1000research.153670.1.

References
1.
Baker M . When antibodies mislead: the quest for validation. Nature. 2020; 585(7824):313-314. DOI: 10.1038/d41586-020-02549-1. View

2.
Voskuil J, Bandrowski A, Begley C, Bradbury A, Chalmers A, Gomes A . The Antibody Society's antibody validation webinar series. MAbs. 2020; 12(1):1794421. PMC: 7531563. DOI: 10.1080/19420862.2020.1794421. View

3.
Ellis M, Lekka C, Holden K, Tulmin H, Seedat F, OBrien D . Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry. Acta Neuropathol. 2024; 147(1):87. PMC: 11102361. DOI: 10.1007/s00401-024-02729-7. View

4.
Andersson S, Sundberg M, Pristovsek N, Ibrahim A, Jonsson P, Katona B . Insufficient antibody validation challenges oestrogen receptor beta research. Nat Commun. 2017; 8:15840. PMC: 5501969. DOI: 10.1038/ncomms15840. View

5.
Rot A, Gutjahr J, Biswas A, Aslani M, Hub E, Thiriot A . Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1. Cell Stem Cell. 2022; 29(7):1013-1015. DOI: 10.1016/j.stem.2021.11.010. View